NCT04447950

Brief Summary

Lumbar spinal decompression and fusion is a commonly performed procedure fro neural impingement and back pain from a variety of pathologies. The importance of pain control in the postoperative period for spinal surgery has been discussed and proven extensively, with both immediate and delayed reduction in complications and improved clinical results. Quadratus lumborum (QL) block was introduced in 2007 and is performed under ultrasound guidance for perioperative pain management in various surgeries.However, the plane for a posterior QL block can be easily reached during open midline spinal surgery. The investigators hypothesize that the posterior QL block is an effective analgesic tool for lumbar laminectomy surgery, because in lumbar laminectomy the quadratus lumborum is already exposed and is in direct visual contact. For that reason it is imperative to test the benefits of this procedure. This is a double blinded randomized control study to assess the results of intra-operative QL block performed for lumbar decompression and fusion.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2020

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2020

Completed
19 days until next milestone

First Submitted

Initial submission to the registry

June 20, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 25, 2020

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2021

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2021

Completed
Last Updated

June 25, 2020

Status Verified

June 1, 2020

Enrollment Period

11 months

First QC Date

June 20, 2020

Last Update Submit

June 24, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in the use of post-operative narcotics

    Difference in MME (morphine milligrams equivalent) of inpatient narcotics consumption.

    Will be reported for each postoperative day during the inpatient stay of the patient to a maximum of 7 days.

Study Arms (2)

Study group

EXPERIMENTAL

Posterior QL block with 20-40 cc of Bupivocaine in posterior border of Quadratum Lumborum muscle at the end of the operation.

Procedure: Type 2/posterior Quadratus Lumborum block

Placebo group

PLACEBO COMPARATOR

Posterior QL block with 40 cc of Saline in posterior border of Quadratum Lumborum muscle at the end of the operation.

Procedure: Placebo block with Saline

Interventions

Injection of local anaesthetic into posterior boundry of Quadratus Lumborum muscle.

Study group

Injection of saline into posterior boundary of Quadratus Lumborum muscle.

Placebo group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Men and women at the ages of 18-80 suffering from leg + back pain or neurological claudication.
  • Undergoing an elective 1-3 level lumbar laminectomy \& fusion at Assuta medical center.

You may not qualify if:

  • Chronic narcotic treatment (more than 3 months)
  • Current active Infection.
  • Underwent any other major operation in the last two months.
  • Known hypersensitivity to local anaesthetic
  • Previous lumbar instrumentation (revision of decompression to decompression with fusion will be included)
  • Non Ambulatory patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Israeli spine center, Assuta medical center

Tel Aviv, 69710, Israel

Location

Related Publications (7)

  • Benz RJ, Garfin SR. Current techniques of decompression of the lumbar spine. Clin Orthop Relat Res. 2001 Mar;(384):75-81. doi: 10.1097/00003086-200103000-00010.

    PMID: 11249182BACKGROUND
  • Elsharkawy H. Quadratus Lumborum Blocks. Adv Anesth. 2017;35(1):145-157. doi: 10.1016/j.aan.2017.07.007. Epub 2017 Oct 3. No abstract available.

    PMID: 29103570BACKGROUND
  • Iwamitsu R, Ueshima H, Otake H. RETRACTED: Intermittent bilateral posterior quadratus lumborum block was effective for pain management in lumbar spinal fusion. J Clin Anesth. 2017 Nov;42:16. doi: 10.1016/j.jclinane.2017.08.012. Epub 2017 Aug 6. No abstract available.

    PMID: 28793274BACKGROUND
  • Ueshima H, Otake H. RETRACTED: Clinical experience of anterior quadratus lumborum block after lumber surgery. J Clin Anesth. 2017 Feb;37:131. doi: 10.1016/j.jclinane.2016.12.014. Epub 2017 Jan 9. No abstract available.

    PMID: 28235503BACKGROUND
  • Yoo JS, Ahn J, Buvanendran A, Singh K. Multimodal analgesia in pain management after spine surgery. J Spine Surg. 2019 Sep;5(Suppl 2):S154-S159. doi: 10.21037/jss.2019.05.04.

    PMID: 31656869BACKGROUND
  • Pugely AJ, Martin CT, Gao Y, Mendoza-Lattes S. Causes and risk factors for 30-day unplanned readmissions after lumbar spine surgery. Spine (Phila Pa 1976). 2014 Apr 20;39(9):761-8. doi: 10.1097/BRS.0000000000000270.

    PMID: 24525993BACKGROUND
  • McDonnell JG, O'Donnell B, Curley G, Heffernan A, Power C, Laffey JG. The analgesic efficacy of transversus abdominis plane block after abdominal surgery: a prospective randomized controlled trial. Anesth Analg. 2007 Jan;104(1):193-7. doi: 10.1213/01.ane.0000250223.49963.0f.

    PMID: 17179269BACKGROUND

MeSH Terms

Conditions

Spondylolisthesis

Interventions

Sodium Chloride

Condition Hierarchy (Ancestors)

SpondylolysisSpondylosisSpinal DiseasesBone DiseasesMusculoskeletal Diseases

Intervention Hierarchy (Ancestors)

ChloridesHydrochloric AcidChlorine CompoundsInorganic ChemicalsSodium Compounds

Study Officials

  • Ely Ashkenazy, MD

    Neurosurgeon, Assuta medical center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ely Ashkenazy, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Masking Details
Rotating nurse assigning the arm, scrubbed nurse preparing syringe for injection with a clear liquid - saline vs saline and Marcaine, surgeon blinded to type of liquid in syringe.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: 2 arms of a RCT.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr Ely Ashkenazy, neurosurgeon

Study Record Dates

First Submitted

June 20, 2020

First Posted

June 25, 2020

Study Start

June 1, 2020

Primary Completion

May 1, 2021

Study Completion

August 1, 2021

Last Updated

June 25, 2020

Record last verified: 2020-06

Data Sharing

IPD Sharing
Will not share

Locations